You just read:

German Health Technology Assessment Body (IQWiG) Concludes Only Oncotype DX® has Sufficient Evidence to Guide Breast Cancer Adjuvant Chemotherapy Decisions Based on Landmark TAILORx Study Results

News provided by

Genomic Health, Inc.

Sep 07, 2018, 08:00 ET